Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hearing Loss × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 26 Pain, Postoperative 17 Neoplasms 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Lung Neoplasms 12 Brain Neoplasms 10 Prostatic Neoplasms 9 Ovarian Neoplasms 9 Colorectal Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Hepatocellular 7 Depression 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Head and Neck Neoplasms 5 Pain 4 Multiple Myeloma 4 Lymphoma 4 Leiomyoma 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Thromboembolism 3 Supratentorial Neoplasms 3 Stomatitis 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Myofibroma 3 Lymphoma, Non-Hodgkin 3

Interventions

sodium thiosulfate 3 ebselen 2 Ankle Brachial Index 2 Acetylcysteine 2 Tomography, X-Ray Computed 1 Sodium Chloride 1 Saline Solution 1 Ringer's Lactate 1 Radiotherapy 1 Radiosurgery 1 Platinum 1 Ofloxacin 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Hyaluronic Acid 1 Hearing Tests 1 Hearing 1 Genetic Association Studies 1 Ear Protective Devices 1 Drug Therapy 1 Cisplatin 1 Chemoradiotherapy 1 Carboplatin 1 Audiometry, Pure-Tone 1 Atorvastatin 1 Acoustic Impedance Tests 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡